Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1338 of 5804
-
Dental text alerts could curb HIV spread
Prevention Recruiting nowThis is a 3-year study to test the efficacy of a text message-based intervention program. Dental patients at 4 community health centers (n= 266) will be randomized to receive either text messages (TMs) regarding HIV prevention or TMs regarding overall wellness. Prior to enrolling…
Phase: NA • Sponsor: Boston University • Aim: Prevention
Last updated Jul 03, 2026 00:00 UTC
-
East palestine Residents' DNA under microscope after toxic train wreck
Knowledge-focused Recruiting nowThe goal of this study is to This research team is conducting this study to develop methods to measure the biological impact of exposure to the chemicals released following the February 3, 2023 train derailment on residents of East Palestine, Ohio, and surrounding communities. Th…
Phase: NA • Sponsor: Case Comprehensive Cancer Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:01 UTC
-
CBD shows promise in curbing alcohol cravings in new study
Disease control Recruiting nowThis human laboratory study aims to assess the effects of cannabidiol on alcohol consumption and craving in participants with alcohol use disorder. In this double-blind within-subject placebo-controlled crossover trial, participants will be randomized to receive both cannabidiol …
Phase: PHASE2 • Sponsor: Centre for Addiction and Mental Health • Aim: Disease control
Last updated Jun 27, 2026 11:03 UTC
-
Dissolving iron stent offers hope for aortic narrowing
Disease control Recruiting nowA single-center, feasible clinical study to Evaluate the Treatment of Iron Bioresorbable Covered Scaffold System in patients with Coarctation of the Aorta Diseases
Phase: NA • Sponsor: Shubo Song • Aim: Disease control
Last updated Jun 27, 2026 08:09 UTC
-
Could dead donors provide Life-Saving bone marrow?
Disease control OngoingThe goal of this clinical trial is to determine the safety and feasibility of allogeneic transplantation with bone marrow from a deceased donor in patients with acute and chronic leukemias, myelodysplastic syndrome, and certain lymphomas. Patients will either receive myeloablativ…
Phase: PHASE1, PHASE2 • Sponsor: Ossium Health, Inc. • Aim: Disease control
Last updated Jul 22, 2026 00:00 UTC
-
Robot buddy eases Kids' needle pain: AI distraction works better than standard care
Symptom relief CompletedChildren experience pain and distress in clinical settings every day. The negative consequences of unaddressed pain can be both short-term (e.g. fear, distress, inability to perform procedures) and long-term (e.g. needle phobia, anxiety). In previous small studies, a humanoid ro…
Phase: NA • Sponsor: University of Alberta • Aim: Symptom relief
Last updated Jun 27, 2026 07:58 UTC
-
AR tech could make lung surgery less painful and cheaper
Symptom relief CompletedWith the popularization of CT screening, the detection rate of small lung nodules has greatly increased. Therefore, the clinical thoracoscopic lung nodule biopsy and sub-lobectomy for radical resection of lung cancer are greatly required. Accurate resection of lung nodule depends…
Phase: NA • Sponsor: Shanghai Chest Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 08:00 UTC
-
AI eye exams: chatbots take on ophthalmologists in landmark trial
Diagnosis CompletedOphthalmic diseases are a major category of conditions affecting visual health, including but not limited to cataracts, glaucoma, retinal and choroidal diseases, and refractive errors (such as myopia, hyperopia, and astigmatism). With the advancement of technology, artificial int…
Sponsor: North Sichuan Medical College • Aim: Diagnosis
Last updated Jun 26, 2026 13:39 UTC
-
New pill aims to calm Alzheimer's psychosis in landmark trial
Symptom relief Recruiting nowThis is a multicenter, randomized, double-blind, parallel-group, placebo-controlled, flexible-dose study evaluating the efficacy, safety, and tolerability of ITI-1284 compared with placebo in the treatment of psychosis in patients with AD.
Phase: PHASE2 • Sponsor: Intra-Cellular Therapies, Inc. • Aim: Symptom relief
Last updated Jul 26, 2026 00:00 UTC
-
Could these eye drops replace reading glasses? new trial tests a daily drop for aging eyes
Symptom relief CompletedSafety and efficacy of POS in participants with presbyopia
Phase: PHASE3 • Sponsor: Ocuphire Pharma, Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 11:01 UTC
-
Robot amplifies stroke Survivors' steps to boost balance
Disease control Recruiting nowStroke is a leading cause of disability in the United States, affecting approximately 795,000 people annually. The Veteran's Health Administration provides over 60,000 outpatient visits for stroke-related care annually at a cost of over $250 million. Among ambulatory people with …
Phase: NA • Sponsor: VA Office of Research and Development • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
Could one month of dual blood thinners after bypass beat aspirin alone?
Disease control Recruiting nowThe purpose of this study is to compare the effect of ticagrelor plus low-dose aspirin versus low-dose aspirin alone in patients with chronic coronary disease undergoing coronary artery bypass grafting.
Phase: PHASE3 • Sponsor: Weill Medical College of Cornell University • Aim: Disease control
Last updated Jun 27, 2026 08:05 UTC
-
New stent aims to keep leg arteries open longer
Disease control Recruiting nowThis is a prospective, open label, multicenter, single arm, first in human clinical study. Patients with infra-inguinal peripheral arterial disease appropriate for treatment with a femoro-popliteal stent will be enrolled. The patients will be treated with the ChampioNIR Stent Sy…
Phase: NA • Sponsor: Medinol Ltd. • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC
-
Could a tailored palliative care approach improve life for heart failure patients?
Symptom relief Recruiting nowThere is evidence for the effectiveness and feasibility of the individual components of TIER-HF-PC, however there is a need to test how these individual components interact to allow the researchers to deliver TIER-HF-PC as a model of care in its totality. In the short term, this …
Phase: NA • Sponsor: National Cancer Centre, Singapore • Aim: Symptom relief
Last updated Jul 18, 2026 00:00 UTC
-
Can a second treatment help kids with SMA who stalled after gene therapy?
Disease control Recruiting nowThis is an open-label, single-arm, multicenter clinical study to evaluate the effectiveness and safety of risdiplam administered in pediatric participants with SMA and 2 SMN2 copies who previously received onasemnogene abeparvovec and experience a plateau or decline in function. …
Phase: PHASE4 • Sponsor: Hoffmann-La Roche • Aim: Disease control
Last updated Jul 11, 2026 00:00 UTC
-
New drug combo targets Hard-to-Treat pancreatic tumors
Disease control Recruiting nowThis phase I trial tests the safety, side effects, and best dose of sunitinib malate in combination with lutetium Lu 177 dotatate in treating patients with pancreatic neuroendocrine tumors. Sunitinib malate is in a class of medications called kinase inhibitors and a form of targe…
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 27, 2026 12:34 UTC
-
New combo drug trial targets Hard-to-Treat sarcomas
Disease control Recruiting nowTo find a recommended dose of gemcitabine and nab-sirolimus that can be given in combination to participants with advanced leiomyosarcomas or soft-tissue sarcomas.
Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 09:07 UTC
-
Could testosterone shots keep prostate cancer at bay?
Disease control Recruiting nowThe WOMBAT study will test if BAT can prolong the time it takes for nmCRPC prostate cancer to become detectable in other areas of the body (metastatic disease). Approximately 69 participants over the age of 18 with castrate resistant prostate cancer, no evidence of metastatic di…
Phase: PHASE2 • Sponsor: Australian and New Zealand Urogenital and Prostate Cancer Trials Group • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Can a phone app save teens from suicide? new trial aims to find out
Symptom relief Recruiting nowDespite efforts to prevent suicide, US rates are climbing, and suicide is the second leading cause of death among youth. Digital tools, especially personal smartphones, are promising avenues to address these issues and can be used to provide a unique understanding of risk factors…
Phase: NA • Sponsor: Ksana Health • Aim: Symptom relief
Last updated Jun 27, 2026 09:11 UTC
-
New liposomal drug takes on advanced cancers
Disease control Recruiting nowAn Open-label, Phase I Dose Escalation and Phase 2 Dose Expansion Study to Assess Safety, Tolerability, Preliminary Antitumor Activity of SMP 3124LP in Adults with Advanced Solid Tumors
Phase: PHASE1, PHASE2 • Sponsor: Sumitomo Pharma America, Inc. • Aim: Disease control
Last updated Jun 27, 2026 09:08 UTC